Close

Prima BioMed (PBMD) Announces European Patent for IMP731 Antibody

August 25, 2016 7:47 AM EDT Send to a Friend
Prima BioMed Ltd (NASDAQ: PBMD) announces the granting of patent number 2142210 entitled “Cytotoxic anti-LAG-3 monoclonal antibody and its use ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login